STAT3 and autoimmune hepatitis: In the case of autoimmune hepatitis, EGCG regulates the hepatic inflammatory microenvironment by inhibiting the NF-κB/STAT3 signaling axis and promotes a balanced state of autophagy and apoptosis to enhance the hepatocyte’s resistance to damage.